Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Chintan Bhavsar, Munira Momin, Tabassum Khan & Abdelwahab Omri. (2018) Targeting tumor microenvironment to curb chemoresistance via novel drug delivery strategies. Expert Opinion on Drug Delivery 15:7, pages 641-663.
Read now
Read now
Elina Simanovich, Vera Brod, Maya M. Rahat, Ella Drazdov, Miriam Walter, Jivan Shakya & Michal A. Rahat. (2017) Inhibition of tumor growth and metastasis by EMMPRIN multiple antigenic peptide (MAP) vaccination is mediated by immune modulation. OncoImmunology 6:1.
Read now
Read now
Norma Bloy, Aitziber Buqué, Fernando Aranda, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Catherine Sautès-Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial watch: Naked and vectored DNA-based anticancer vaccines. OncoImmunology 4:5.
Read now
Read now
Jonathan Pol, Norma Bloy, Aitziber Buqué, Alexander Eggermont, Isabelle Cremer, Catherine Sautès-Fridman, Jérôme Galon, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial Watch: Peptide-based anticancer vaccines. OncoImmunology 4:4.
Read now
Read now
Khashayarsha Khazaie. (2013) Targeted chemo-immunotherapy of leukemia. Leukemia & Lymphoma 54:7, pages 1353-1354.
Read now
Read now
Articles from other publishers (24)
Wei Jiang, Guosheng Gu, Yumin Zhang, Yushuai Song, Ming Shi, Gang Wang, Huizhong Li, Tingting Tao, Jianhua Qin, Xianliang Li, Hongtao Jia, Feng Jiao, Weidong Xu & Xiaoyi Huang. (2023) Novel mesothelin-targeted chimeric antigen receptor-modified UNKT cells are highly effective in inhibiting tumor progression. Pharmacological Research 197, pages 106942.
Crossref
Crossref
Fatemeh Hajibabaie, Navid Abedpoor, Shaghayegh Haghjooy Javanmard, Anwarul Hasan, Mehran Sharifi, Ilnaz Rahimmanesh, Laleh Shariati & Pooyan Makvandi. (2023) The molecular perspective on the melanoma and genome engineering of T-cells in targeting therapy. Environmental Research 237, pages 116980.
Crossref
Crossref
Abdulla Berjis, Deeksha Muthumani, Neil C. Sheppard & Carl H. June. (2023) Swiss army knife T cell: one T cell many tumor targets. Cell Research.
Crossref
Crossref
Dhanashree Murugan, Vasanth Murugesan, Balaji Panchapakesan & Loganathan Rangasamy. (2022) Nanoparticle Enhancement of Natural Killer (NK) Cell-Based Immunotherapy. Cancers 14:21, pages 5438.
Crossref
Crossref
S. Feola, S. Russo, E. Ylösmäki & V. Cerullo. (2022) Oncolytic ImmunoViroTherapy: A long history of crosstalk between viruses and immune system for cancer treatment. Pharmacology & Therapeutics 236, pages 108103.
Crossref
Crossref
Carlos Eduardo Fonseca-Alves. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
13
.
Cristina Teixido, Paola Castillo, Clara Martinez-Vila, Ana Arance & Llucia Alos. (2021) Molecular Markers and Targets in Melanoma. Cells 10:9, pages 2320.
Crossref
Crossref
Jessica S.W. Borgers & John B.A.G. Haanen. (2021) Cellular Therapy and Cytokine Treatments for Melanoma. Hematology/Oncology Clinics of North America 35:1, pages 129-144.
Crossref
Crossref
Georgia Koutsoumpli, Oana Draghiciu, Hans W Nijman, Cesar Oyarce & Toos Daemen. 2021. Cancer Immunology. Cancer Immunology
61
83
.
Mie Linder Hübbe, Ditte Elisabeth Jæhger, Thomas Lars Andresen & Mads Hald Andersen. (2020) Leveraging Endogenous Dendritic Cells to Enhance the Therapeutic Efficacy of Adoptive T-Cell Therapy and Checkpoint Blockade. Frontiers in Immunology 11.
Crossref
Crossref
Heike Loeser, Max Kraemer, Florian Gebauer, Christiane Bruns, Wolfgang Schröder, Thomas Zander, Hakan Alakus, Arnulf Hoelscher, Reinhard Buettner, Philipp Lohneis & Alexander Quaas. (2020) Indoleamine 2,3-Dioxygenase (IDO) Expression Is an Independent Prognostic Marker in Esophageal Adenocarcinoma. Journal of Immunology Research 2020, pages 1-10.
Crossref
Crossref
Svenja Wagener-Ryczek, Max Schoemmel, Max Kraemer, Christiane Bruns, Wolfgang Schroeder, Thomas Zander, Florian Gebauer, Hakan Alakus, Sabine Merkelbach-Bruse, Reinhard Buettner, Heike Loeser, Martin Thelen, Hans A. Schlößer & Alexander Quaas. (2020) Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma. Cancer Immunology, Immunotherapy 69:4, pages 523-533.
Crossref
Crossref
Rosemary Habib, Adnan Nagrial, Kenneth Micklethwaite & Kavitha Gowrishankar. 2020. Tumor Microenvironment. Tumor Microenvironment
117
143
.
Karina Krotova, Andrew Day & George Aslanidi. (2019) An Engineered AAV6-Based Vaccine Induces High Cytolytic Anti-Tumor Activity by Directly Targeting DCs and Improves Ag Presentation. Molecular Therapy - Oncolytics 15, pages 166-177.
Crossref
Crossref
Bianca Simon, Dennis C. Harrer, Beatrice Schuler-Thurner, Gerold Schuler & Ugur Uslu. (2019) Arming T Cells with a gp100-Specific TCR and a CSPG4-Specific CAR Using Combined DNA- and RNA-Based Receptor Transfer. Cancers 11:5, pages 696.
Crossref
Crossref
Arsen Osipov, Adrian Murphy & Lei Zheng. 2019. Immunotherapy of Cancer. Immunotherapy of Cancer
63
144
.
Medea Neek, Jo Anne Tucker, Tae Il Kim, Nicholas M. Molino, Edward L. Nelson & Szu-Wen Wang. (2018) Co-delivery of human cancer-testis antigens with adjuvant in protein nanoparticles induces higher cell-mediated immune responses. Biomaterials 156, pages 194-203.
Crossref
Crossref
Thomas C. Wirth & Florian Kühnel. (2017) Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?. Frontiers in Immunology 8.
Crossref
Crossref
Dennis C. Harrer, Bianca Simon, Shin-ichiro Fujii, Kanako Shimizu, Ugur Uslu, Gerold Schuler, Kerstin F. Gerer, Stefanie Hoyer, Jan Dörrie & Niels Schaft. (2017) RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma. BMC Cancer 17:1.
Crossref
Crossref
Kawther K. Ahmed, Sean M. Geary & Aliasger K. Salem. (2017) Surface engineering tumor cells with adjuvant-loaded particles for use as cancer vaccines. Journal of Controlled Release 248, pages 1-9.
Crossref
Crossref
Keiichiro Mie, Terumasa Shimada, Hideo Akiyoshi, Akiyoshi Hayashi & Fumihito Ohashi. (2016) Change in peripheral blood lymphocyte count in dogs following adoptive immunotherapy using lymphokine-activated T killer cells combined with palliative tumor resection. Veterinary Immunology and Immunopathology 177, pages 58-63.
Crossref
Crossref
Mohammad W. Khan & Viktor Umansky. (2016) Ret mouse very large tumors (VLTs) display altered ratios of infiltrating memory to naive T cells: Roles in tumor expansion. Pathophysiology 23:3, pages 211-220.
Crossref
Crossref
A Sergeeva, H He, K Ruisaard, L St John, G Alatrash, K Clise-Dwyer, D Li, R Patenia, R Hong, P Sukhumalchandra, M J You, M Gagea, Q Ma & J J Molldrem. (2016) Activity of 8F4, a T-cell receptor-like anti-PR1/HLA-A2 antibody, against primary human AML in vivo. Leukemia 30:7, pages 1475-1484.
Crossref
Crossref
Lorenzo Galluzzi, Erika Vacchelli, José-Manuel Bravo-San Pedro, Aitziber Buqué, Laura Senovilla, Elisa Elena Baracco, Norma Bloy, Francesca Castoldi, Jean-Pierre Abastado, Patrizia Agostinis, Ron N. Apte, Fernando Aranda, Maha Ayyoub, Philipp Beckhove, Jean-Yves Blay, Laura Bracci, Anne Caignard, Chiara Castelli, Federica Cavallo, Estaban Celis, Vincenzo Cerundolo, Aled Clayton, Mario P. Colombo, Lisa Coussens, Madhav V. Dhodapkar, Alexander M. Eggermont, Douglas T. Fearon, Wolf H. Fridman, Jitka Fučíková, Dmitry I. Gabrilovich, Jérôme Galon, Abhishek Garg, François Ghiringhelli, Giuseppe Giaccone, Eli Gilboa, Sacha Gnjatic, Axel Hoos, Anne Hosmalin, Dirk Jäger, Pawel Kalinski, Klas Kärre, Oliver Kepp, Rolf Kiessling, John M. Kirkwood, Eva Klein, Alexander Knuth, Claire E. Lewis, Roland Liblau, Michael T. Lotze, Enrico Lugli, Jean-Pierre Mach, Fabrizio Mattei, Domenico Mavilio, Ignacio Melero, Cornelis J. Melief, Elizabeth A. Mittendorf, Lorenzo Moretta, Adekunke Odunsi, Hideho Okada, Anna Karolina Palucka, Marcus E. Peter, Kenneth J. Pienta, Angel Porgador, George C. Prendergast, Gabriel A. Rabinovich, Nicholas P. Restifo, Naiyer Rizvi, Catherine Sautès-Fridman, Hans Schreiber, Barbara Seliger, Hiroshi Shiku, Bruno Silva-Santos, Mark J. Smyth, Daniel E. Speiser, Radek Spisek, Pramod K. Srivastava, James E. Talmadge, Eric Tartour, Sjoerd H. Van Der Burg, Benoît J. Van Den Eynde, Richard Vile, Hermann Wagner, Jeffrey S. Weber, Theresa L. Whiteside, Jedd D. Wolchok, Laurence Zitvogel, Weiping Zou & Guido Kroemer. (2014) Classification of current anticancer immunotherapies. Oncotarget 5:24, pages 12472-12508.
Crossref
Crossref